Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1974 Jun;51(2):187–195. doi: 10.1111/j.1476-5381.1974.tb09646.x

Studies on the metabolism of catecholamines in the central nervous system of the mouse

PM Ceasar, P Hague, DF Sharman, B Werdinius
PMCID: PMC1776743  PMID: 4141637

Abstract

1 The distribution of the metabolites of noradrenaline, 1-(3,4-dihydroxyphenyl)ethane-1,2-diol (DOPEG) and 1-(4-hydroxy-3-methoxyphenyl)ethane-1,2-diol (MOPEG), in the brain of the mouse has been investigated.

2 The rate of disappearance of the metabolites after inhibition of the enzyme monoamine oxidase has been used to estimate their turnover rates in the mouse hypothalamus. It was concluded that the turnover of DOPEG was much faster than that of MOPEG.

3 When mice were treated with reserpine dissolved in 5% ascorbic acid solution there was an increase in the hypothalamic concentration of both MOPEG and DOPEG. However, similar increases in the concentrations of the two metabolites were seen when the animals were treated with 5% ascorbic acid solution alone.

4 The administration of tropolone, an inhibitor of the enzyme catechol-O-methyl transferase, resulted in an increase in the concentration of DOPEG.

5 Mice, exposed to a temperature of -15° C showed increased hypothalamic concentrations of both DOPEG and MOPEG.

6 The rates of formation in the mouse striatum of 3,4-dihydroxyphenylacetic acid (DOPAC) and 4-hydroxy-3-methoxyphenylacetic acid (HVA), acidic metabolites of dopamine, were compared with the turnover rate of dopamine, estimated from the rate at which this catecholamine disappears after treatment with α-methyl-p-tyrosine. It was concluded that the estimate of dopamine turnover obtained by this method is likely to be too large because of the compensatory feedback mechanism which is thought to play a role in the metabolism of dopamine in the brain.

Full text

PDF
187

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andén N. E., Rubenson A., Fuxe K., Hökfelt T. Evidence for dopamine receptor stimulation by apomorphine. J Pharm Pharmacol. 1967 Sep;19(9):627–629. doi: 10.1111/j.2042-7158.1967.tb09604.x. [DOI] [PubMed] [Google Scholar]
  2. BELLEAU B., BURBA J. OCCUPANCY OF ADRENERGIC RECEPTORS AND INHIBITION OF CATECHOL O-METHYL TRANSFERASE BY TROPOLONES. J Med Chem. 1963 Nov;6:755–759. doi: 10.1021/jm00342a028. [DOI] [PubMed] [Google Scholar]
  3. Bliss E. L., Ailion J., Zwanziger J. Metabolism of norepinephrine, serotonin and dopamine in rat brain with stress. J Pharmacol Exp Ther. 1968 Nov;164(1):122–134. [PubMed] [Google Scholar]
  4. Braestrup C. Gas chromatographic evidence for the presence of 3-methoxy-4-hydroxyphenylethanol in rat brain. Biochem Pharmacol. 1972 Jun 15;21(12):1775–1776. doi: 10.1016/0006-2952(72)90084-6. [DOI] [PubMed] [Google Scholar]
  5. CARLSSON A., LINDQVIST M. EFFECT OF CHLORPROMAZINE OR HALOPERIDOL ON FORMATION OF 3METHOXYTYRAMINE AND NORMETANEPHRINE IN MOUSE BRAIN. Acta Pharmacol Toxicol (Copenh) 1963;20:140–144. doi: 10.1111/j.1600-0773.1963.tb01730.x. [DOI] [PubMed] [Google Scholar]
  6. DINGELL J. V., SULSER F., GILLETTE J. R. SPECIES DIFFERENCES IN THE METABOLISM OF IMIPRAMINE AND DESMETHYLIMIPRAMINE (DMI). J Pharmacol Exp Ther. 1964 Jan;143:14–22. [PubMed] [Google Scholar]
  7. Izquierdo J. A., Jofré I. J., Acevedo C. The effect of ascorbic acid on the cerebral and adrenal catecholamine content in the male rat. J Pharm Pharmacol. 1968 Mar;20(3):210–214. doi: 10.1111/j.2042-7158.1968.tb09723.x. [DOI] [PubMed] [Google Scholar]
  8. KOPIN I. J., GORDON E. K. Metabolism of norepinephrine-H3 released by tyramine and reserpine. J Pharmacol Exp Ther. 1962 Dec;138:351–359. [PubMed] [Google Scholar]
  9. LAVERTY R., SHARMAN D. F. THE ESTIMATION OF SMALL QUANTITIES OF 3,4-DIHYDROXYPHENYLETHYLAMINE IN TISSUES. Br J Pharmacol Chemother. 1965 Apr;24:538–548. doi: 10.1111/j.1476-5381.1965.tb01744.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. MAYNERT E. W., LEVI R. STRESS-INDUCED RELEASE OF BRAIN NOREPINEPHRINE AND ITS INHIBITION BY DRUGS. J Pharmacol Exp Ther. 1964 Jan;143:90–95. [PubMed] [Google Scholar]
  11. Meek J. L., Neff N. H. Fluorometric estimation of 4-hydroxy-3-methoxyphenylethyleneglycol sulphate in brain. Br J Pharmacol. 1972 Jul;45(3):435–441. doi: 10.1111/j.1476-5381.1972.tb08099.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Murphy G. F., Robinson D., Sharman D. F. The effect of tropolone on the formation of 3,4-dihydroxyphenylacetic acid and 4-hydroxy-3-methoxyphenylacetic acid in the brain of the mouse. Br J Pharmacol. 1969 May;36(1):107–115. doi: 10.1111/j.1476-5381.1969.tb08308.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Neef N. H., Tozer T. N., Brodie B. B. Application of seady-state kinetics to studies of the transfer of 5-hydroxyindoleacetic acid from brain to plasma. J Pharmacol Exp Ther. 1967 Nov;158(2):214–218. [PubMed] [Google Scholar]
  14. Roffler-Tarlov S., Sharman D. F., Tegerdine P. 3,4-dihydroxyphenylacetic acid and 4-hydroxy-3-methoxyphenylacetic acid in the mouse striatum: a reflection of intra- and extra-neuronal metabolism of dopamine? Br J Pharmacol. 1971 Jul;42(3):343–351. doi: 10.1111/j.1476-5381.1971.tb07118.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Roos B. E. Decrease in homovanillic acid as evidence for dopamine receptor stimulation by apomorphine in the neostriatum of the rat. J Pharm Pharmacol. 1969 Apr;21(4):263–264. doi: 10.1111/j.2042-7158.1969.tb08243.x. [DOI] [PubMed] [Google Scholar]
  16. SPECTOR S., SJOERDSMA A., UDENFRIEND S. BLOCKADE OF ENDOGENOUS NOREPINEPHRINE SYNTHESIS BY ALPHA-METHYL-TYROSINE, AN INHIBITOR OF TYROSINE HYDROXYLASE. J Pharmacol Exp Ther. 1965 Jan;147:86–95. [PubMed] [Google Scholar]
  17. Saelens J. K., Schoen M. S., Kovacsics G. B. An enzyme assay for norepinephrine in brain tissue. Biochem Pharmacol. 1967 Jun;16(6):1043–1049. doi: 10.1016/0006-2952(67)90277-8. [DOI] [PubMed] [Google Scholar]
  18. Sharman D. F. Changes in the metabolism of 3,4-dihydroxyphenylethylamine (dopamine) in the striatum of the mouse induced by drugs. Br J Pharmacol Chemother. 1966 Nov;28(2):153–163. doi: 10.1111/j.1476-5381.1966.tb01881.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Sharman D. F. Glycol metabolites of noradrenaline in brain tissue. Br J Pharmacol. 1969 Jul;36(3):523–534. doi: 10.1111/j.1476-5381.1969.tb08008.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Simmonds M. A. Effect of environmental temperature on the turnover of noradrenaline in hypothalamus and other areas of rat brain. J Physiol. 1969 Jul;203(1):199–210. doi: 10.1113/jphysiol.1969.sp008859. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Spano P. F., Neff N. H. Metabolic fate of caudate nucleus dopamine. Brain Res. 1972 Jul 13;42(1):139–145. doi: 10.1016/0006-8993(72)90048-0. [DOI] [PubMed] [Google Scholar]
  22. Tarlov S. R., Langer S. Z. The fate of 3 H-norepinephrine released from isolated atria and vas deferens: effect of field stimulation. J Pharmacol Exp Ther. 1971 Nov;179(2):186–197. [PubMed] [Google Scholar]
  23. Thierry A. M., Blanc G., Glowinski J. Effect of stress on the disposition of catecholamines localized in various intraneuronal storage forms in the brain stem of the rat. J Neurochem. 1971 Mar;18(3):449–461. doi: 10.1111/j.1471-4159.1971.tb11972.x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES